EMBO Reports,
Journal Year:
2022,
Volume and Issue:
23(6)
Published: May 8, 2022
The
severe-acute-respiratory-syndrome-coronavirus-2
(SARS-CoV-2)
is
the
causative
agent
of
COVID-19,
but
host
cell
factors
contributing
to
COVID-19
pathogenesis
remain
only
partly
understood.
We
identify
metalloprotease
ADAM17
as
a
facilitator
SARS-CoV-2
entry
and
ADAM10
factor
required
for
lung
syncytia
formation,
hallmark
pathology.
ADAM17,
which
are
broadly
expressed
in
human
lung,
cleave
spike
protein
(S)
vitro,
indicating
that
contribute
priming
S,
an
essential
step
viral
fusion.
ADAM
protease-targeted
inhibitors
severely
impair
infection
by
variants
concern
alpha,
beta,
delta,
omicron
also
reduce
primary
cells
TMPRSS2
protease-independent
manner.
Our
study
establishes
formation
defines
both
proteases
potential
targets
antiviral
drug
development.
Cell Systems,
Journal Year:
2020,
Volume and Issue:
12(1), P. 23 - 40.e7
Published: Oct. 8, 2020
We
performed
RNA-seq
and
high-resolution
mass
spectrometry
on
128
blood
samples
from
COVID-19-positive
COVID-19-negative
patients
with
diverse
disease
severities
outcomes.
Quantified
transcripts,
proteins,
metabolites,
lipids
were
associated
clinical
outcomes
in
a
curated
relational
database,
uniquely
enabling
systems
analysis
cross-ome
correlations
to
molecules
patient
prognoses.
mapped
219
molecular
features
high
significance
COVID-19
status
severity,
many
of
which
involved
complement
activation,
dysregulated
lipid
transport,
neutrophil
activation.
identified
sets
covarying
molecules,
e.g.,
protein
gelsolin
metabolite
citrate
or
plasmalogens
apolipoproteins,
offering
pathophysiological
insights
therapeutic
suggestions.
The
observed
dysregulation
platelet
function,
coagulation,
acute
phase
response,
endotheliopathy
further
illuminated
the
unique
phenotype.
present
web-based
tool
(covid-omics.app)
interactive
exploration
our
compendium
illustrate
its
utility
through
machine
learning
approach
for
prediction
severity.
Nature,
Journal Year:
2022,
Volume and Issue:
603(7899), P. 145 - 151
Published: Jan. 19, 2022
Abstract
COVID-19,
which
is
caused
by
infection
with
SARS-CoV-2,
characterized
lung
pathology
and
extrapulmonary
complications
1,2
.
Type
I
interferons
(IFNs)
have
an
essential
role
in
the
pathogenesis
of
COVID-19
(refs
3–5
).
Although
rapid
induction
type
IFNs
limits
virus
propagation,
a
sustained
increase
levels
late
phase
associated
aberrant
inflammation
poor
clinical
outcome
5–17
Here
we
show
that
cyclic
GMP-AMP
synthase
(cGAS)–stimulator
interferon
genes
(STING)
pathway,
controls
immunity
to
cytosolic
DNA,
critical
driver
IFN
responses
(ref.
18
Profiling
skin
manifestations,
uncover
STING-dependent
signature
primarily
mediated
macrophages
adjacent
areas
endothelial
cell
damage.
Moreover,
cGAS–STING
activity
was
detected
samples
from
patients
prominent
tissue
destruction,
responses.
A
lung-on-chip
model
revealed
that,
addition
macrophages,
SARS-CoV-2
activates
signalling
cells
through
mitochondrial
DNA
release,
leads
death
production.
In
mice,
pharmacological
inhibition
STING
reduces
severe
induced
improves
disease
outcome.
Collectively,
our
study
establishes
mechanistic
basis
pathological
reveals
principle
for
development
host-directed
therapeutics.
Nature Communications,
Journal Year:
2021,
Volume and Issue:
12(1)
Published: June 21, 2021
Viruses
manipulate
cellular
metabolism
and
macromolecule
recycling
processes
like
autophagy.
Dysregulated
might
lead
to
excessive
inflammatory
autoimmune
responses
as
observed
in
severe
long
COVID-19
patients.
Here
we
show
that
SARS-CoV-2
modulates
reduces
Accordingly,
compound-driven
induction
of
autophagy
limits
propagation.
In
detail,
SARS-CoV-2-infected
cells
accumulation
key
metabolites,
activation
inhibitors
(AKT1,
SKP2)
reduction
proteins
responsible
for
initiation
(AMPK,
TSC2,
ULK1),
membrane
nucleation,
phagophore
formation
(BECN1,
VPS34,
ATG14),
well
autophagosome-lysosome
fusion
ATG14
oligomers).
Consequently,
phagophore-incorporated
markers
LC3B-II
P62
accumulate,
which
confirm
a
hamster
model
lung
samples
Single-nucleus
single-cell
sequencing
patient-derived
mucosal
differential
transcriptional
regulation
immune
genes
depending
on
cell
type,
disease
duration,
replication
levels.
Targeting
autophagic
pathways
by
exogenous
administration
the
polyamines
spermidine
spermine,
selective
AKT1
inhibitor
MK-2206,
BECN1-stabilizing
anthelmintic
drug
niclosamide
inhibit
propagation
vitro
with
IC
Cell Reports,
Journal Year:
2021,
Volume and Issue:
35(7), P. 109126 - 109126
Published: April 27, 2021
Severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2)
evades
most
innate
immune
responses
but
may
still
be
vulnerable
to
some.
Here,
we
systematically
analyze
the
impact
of
SARS-CoV-2
proteins
on
interferon
(IFN)
and
autophagy.
We
show
that
synergize
counteract
anti-viral
responses.
For
example,
Nsp14
targets
type
I
IFN
receptor
for
lysosomal
degradation,
ORF3a
prevents
fusion
autophagosomes
lysosomes,
ORF7a
interferes
with
autophagosome
acidification.
Most
activities
are
evolutionarily
conserved.
However,
Nsp15
antagonizes
signaling
less
efficiently
than
orthologs
closely
related
RaTG13-CoV
SARS-CoV-1.
Overall,
autophagy
more
II
or
III
signaling,
infection
experiments
confirm
potent
inhibition
by
IFN-γ
-λ1.
Our
results
define
repertoire
selected
mechanisms
antagonists
also
reveal
vulnerability
help
develop
safe
effective
approaches.
Proceedings of the National Academy of Sciences,
Journal Year:
2022,
Volume and Issue:
119(35)
Published: Aug. 11, 2022
Although
increasing
evidence
confirms
neuropsychiatric
manifestations
associated
mainly
with
severe
COVID-19
infection,
long-term
dysfunction
(recently
characterized
as
part
of
"long
COVID-19"
syndrome)
has
been
frequently
observed
after
mild
infection.
We
show
the
spectrum
cerebral
impact
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2)
ranging
from
alterations
in
mildly
infected
individuals
(orbitofrontal
cortical
atrophy,
neurocognitive
impairment,
excessive
fatigue
and
anxiety
symptoms)
to
damage
confirmed
brain
tissue
samples
extracted
orbitofrontal
region
(via
endonasal
transethmoidal
access)
who
died
COVID-19.
In
an
independent
cohort
26
COVID-19,
we
used
histopathological
signs
a
guide
for
possible
SARS-CoV-2
infection
found
that
among
5
exhibited
those
signs,
all
them
had
genetic
material
virus
brain.
Brain
these
five
patients
also
foci
replication,
particularly
astrocytes.
Supporting
hypothesis
astrocyte
neural
stem
cell-derived
human
astrocytes
vitro
are
susceptible
through
noncanonical
mechanism
involves
spike-NRP1
interaction.
SARS-CoV-2-infected
manifested
changes
energy
metabolism
key
proteins
metabolites
fuel
neurons,
well
biogenesis
neurotransmitters.
Moreover,
elicits
secretory
phenotype
reduces
neuronal
viability.
Our
data
support
model
which
reaches
brain,
infects
astrocytes,
consequently,
leads
death
or
dysfunction.
These
deregulated
processes
could
contribute
structural
functional
seen
brains
patients.
Journal of Cachexia Sarcopenia and Muscle,
Journal Year:
2022,
Volume and Issue:
13(1), P. 11 - 22
Published: Jan. 7, 2022
Abstract
Skeletal
muscle‐related
symptoms
are
common
in
both
acute
coronavirus
disease
(Covid)‐19
and
post‐acute
sequelae
of
Covid‐19
(PASC).
In
this
narrative
review,
we
discuss
cellular
molecular
pathways
that
affected
consider
these
regard
to
skeletal
muscle
involvement
other
conditions,
such
as
respiratory
distress
syndrome,
critical
illness
myopathy,
post‐viral
fatigue
syndrome.
Patients
with
severe
PASC
suffer
from
weakness
exercise
intolerance.
Histological
sections
present
fibre
atrophy,
metabolic
alterations,
immune
cell
infiltration.
Contributing
factors
patients
include
systemic
inflammation,
disuse,
hypoxaemia,
malnutrition.
These
also
contribute
post‐intensive
care
unit
(ICU)
syndrome
ICU‐acquired
likely
explain
a
substantial
part
Covid‐19‐acquired
weakness.
The
intolerance
associated
more
obscure.
Direct
(SARS‐CoV)‐2
viral
infiltration
into
or
an
aberrant
system
contribute.
Similarities
between
alterations
chronic
deserve
further
study.
Both
SARS‐CoV‐2‐specific
generic
consequences
underlie
the
observed
PASC.